{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:44Z","timestamp":1792403924535,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.11.008","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:00:55Z","timestamp":1736398855000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A retrospective study on ruthenium-106 and strontium-90 eye-plaques treatment for retinoblastoma: 16-years clinical experience"],"prefix":"10.1016","volume":"24","author":[{"given":"Andrey A.","family":"Yarovoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-7803","authenticated-orcid":false,"given":"Denis P.","family":"Volodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A.","family":"Yarovaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.11.008_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjo.2008.138750","article-title":"Incidence of retinoblastoma in the USA: 1975-2004","volume":"93","author":"Broaddus","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0002","first-page":"685","article-title":"Global retinoblastoma presentation and analysis by national income level","volume":"6","author":"Fabian","year":"2024","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.brachy.2024.11.008_bib0003","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: The long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.11.008_bib0004","first-page":"726","article-title":"Use of intra-arterial chemotherapy for retinoblastoma: Results of a survey","volume":"7","author":"Grigorovski","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: Outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.11.008_bib0006","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3928\/01913913-20160719-04","article-title":"Retinoblastoma control with primary intra-arterial chemotherapy: Outcomes before and during the intravitreal chemotherapy era","volume":"53","author":"Shields","year":"2016","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.brachy.2024.11.008_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696787","article-title":"Safety and efficacy of intravitreal chemotherapy (melphalan) to treat vitreous seeds in retinoblastoma","volume":"12","author":"Yousef","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0008","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: Outcomes after 192 consecutive injections. The 2015 Howard Naquin Lecture","volume":"36","author":"Shields","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.brachy.2024.11.008_bib0009","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0161-6420(93)31667-2","article-title":"Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment","volume":"100","author":"Shields","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"Electronic address: paulfinger@eyecancer.Com; ABS \u2013 OOTF Committee. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.008_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pbc.20094","article-title":"Episcleral plaque brachytherapy for retinoblastoma","volume":"43","author":"Merchant","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.brachy.2024.11.008_bib0012","doi-asserted-by":"crossref","first-page":"285","DOI":"10.24953\/turkjped.2021.4217","article-title":"Episcleral Iodine-125 radioactive plaque brachytherapy as a salvage treatment for retinoblastoma in the era of intraarterial chemotherapy","volume":"64","author":"Sar\u0131c\u0131","year":"2022","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.brachy.2024.11.008_bib0013","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0161-6420(01)00797-7","article-title":"Plaque radiotherapy for retinoblastoma: Long-term tumor control and treatment complications in 208 tumors","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.11.008_bib0014","article-title":"Palladium-103 plaque brachytherapy for retinoblastoma: Long term follow up","volume":"27","author":"Maheshwari","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.brachy.2024.11.008_bib0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2007.11.004","article-title":"(106)Ruthenium brachytherapy for retinoblastoma","volume":"71","author":"Abouzeid","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.008_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000088259","article-title":"Beta-ray brachytherapy of retinoblastoma: Feasibility of a new small-sized ruthenium-106 plaque","volume":"38","author":"Schueler","year":"2006","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.brachy.2024.11.008_bib0017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2011.11.002","article-title":"\u00b9\u2070\u2076Ruthenium plaque therapy (RPT) for retinoblastoma","volume":"84","author":"Murakami","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.008_bib0018","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000520952","article-title":"Combination of brachytherapy and intravitreal chemotherapy in the treatment of retinoblastoma with vitreous seeding","volume":"8","author":"Schl\u00fcter","year":"2022","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0019","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/13816810.2022.2141795","article-title":"Ruthenium plaque radiotherapy in the current era of retinoblastoma treatment","volume":"43","author":"Negretti","year":"2022","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.brachy.2024.11.008_bib0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archophthalmol.2008.626","article-title":"Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0021","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0022","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0301-4738.190143","article-title":"Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study","volume":"64","author":"Chawla","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0023","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bjo.15.12.673","article-title":"Retinal gliomata treated by radon seeds","volume":"15","author":"Moore","year":"1931","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0024","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/bjo.32.9.618","article-title":"Radiotherapy of malignant intra-ocular neoplasm","volume":"32","author":"Stallard","year":"1948","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.11.008_bib0025","first-page":"254","article-title":"Long term follow-up results of external beam radiotherapy as primary treatment for retinoblastoma","volume":"546","author":"Choi","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.brachy.2024.11.008_bib0026","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3349\/ymj.2015.56.6.1478","article-title":"Treatment of retinoblastoma: the role of external beam radiotherapy","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:38:18Z","timestamp":1740746298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124004586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538472124004586"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.008","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study on ruthenium-106 and strontium-90 eye-plaques treatment for retinoblastoma: 16-years clinical experience","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}